UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Prevalence of BRCA and VUS mutations in patients with ovarian cancer treated at oncosalud: AUNA

Annals of oncology, 2018-11, Vol.29, p.ix84-ix84

2018

Link zum Volltext

Verfügbarkeit prüfen

P-6 Spatio-temporal distribution pattern of pancreatic cancer mortality rate in Peru between 2003-2017

Annals of oncology, 2021-07, Vol.32, p.S98

2021

Link zum Volltext

Verfügbarkeit prüfen

P-62 Overall survival of patients with pancreatic cancer

Annals of oncology, 2021-07, Vol.32, p.S117-S118

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

Annals of oncology, 2019-10, Vol.30, p.v129

2019

Link zum Volltext

Verfügbarkeit prüfen

356P - Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

Annals of oncology, 2019-10, Vol.30, p.v129-v129

2019

Link zum Volltext

Verfügbarkeit prüfen

362P - Patterns and predictors of first-line (1L) taxane use in US patients with metastatic triple-negative breast cancer (mTNBC)

Annals of oncology, 2019-10, Vol.30, p.v132-v132

2019

Link zum Volltext

Verfügbarkeit prüfen

Patterns and predictors of first-line (1L) taxane use in US patients with metastatic triple-negative breast cancer (mTNBC)

Annals of oncology, 2019-10, Vol.30, p.v132

2019

Link zum Volltext

Verfügbarkeit prüfen

The immune modulation role of low dosage of cyclosporin-A (ldCSA) in the antitumor response of CD8+ T lymphocytes (CD8+Tcells) and the implication of neuropilin-1 (Nrp1)

Annals of oncology, 2017-12, Vol.28, p.xi21-xi21

2017

Link zum Volltext

Verfügbarkeit prüfen

196P Neoadjuvant and adjuvant chemotherapy (NACT/ACT) treatment (tx) patterns in a real-world cohort of US pts with early triple-negative breast cancer (eTNBC)

Annals of oncology, 2020-09, Vol.31, p.S321-S321

2020

Link zum Volltext

Verfügbarkeit prüfen

271PPrevalence of BRCA and VUS mutations in patients with ovarian cancer treated at oncosalud: AUNA

Annals of oncology, 2018-11, Vol.29 (suppl_9)

2018

Link zum Volltext

Verfügbarkeit prüfen

1456P Impact of early palliative care in quality at the end of life in small cell lung cancer patients

Annals of oncology, 2021-09, Vol.32, p.S1081-S1081

2021

Link zum Volltext

Verfügbarkeit prüfen

A Multidisciplinary Approach to Heredofamilial Cancer Syndromes: Evaluation of the First Four Years of Experience at a Spanish University Hospital

Annals of oncology, 2014-09, Vol.25, p.iv166

2014

Link zum Volltext

Verfügbarkeit prüfen

356PUse of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

362PPatterns and predictors of first-line (1L) taxane use in US patients with metastatic triple-negative breast cancer (mTNBC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of breast cancer patients with genetic risk: Before and after a multidisciplinary heredofamiliar cancer unit implementation

Annals of oncology, 2016-10, Vol.27, p.vi465-vi465

2016

Link zum Volltext

Verfügbarkeit prüfen

Treatment Outcomes and Prognostic Factors in Mexican Patients with Endometrial Carcinoma: the Latin American Experience

Annals of oncology, 2012-09, Vol.23, p.ix329

2012

Link zum Volltext

Verfügbarkeit prüfen

1003P - Treatment Outcomes and Prognostic Factors in Mexican Patients with Endometrial Carcinoma: the Latin American Experience

Annals of oncology, 2012-09, Vol.23, p.ix329-ix329

2012

Link zum Volltext

Verfügbarkeit prüfen

496PA MULTIDISCIPLINARY APPROACH TO HEREDOFAMILIAL CANCER SYNDROMES: EVALUATION OF THE FIRST FOUR YEARS OF EXPERIENCE AT A SPANISH UNIVERSITY HOSPITAL

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv166-iv166

2014

Link zum Volltext

Verfügbarkeit prüfen

Impact of invasive lobular carcinoma in Latin American breast cancer patients’ disease-free survival: The new paradox

Annals of oncology, 2018-10, Vol.29, p.viii675-viii675

2018

Link zum Volltext

Verfügbarkeit prüfen

Association between obesity and efficacy of chemoradiotherapy in rectal cancer patients

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii169-viii170

2018

Link zum Volltext

Verfügbarkeit prüfen

346P Influence of single nucleotide polymorphisms in genes involved in capecitabine activation pathway on treatment toxicity in patients with colorectal cancer

Annals of oncology, 2022-09, Vol.33, p.S694-S695

2022

Link zum Volltext

Verfügbarkeit prüfen

350P Quality of life data on sexual relations in early breast cancer patients

Annals of oncology, 2023-10, Vol.34, p.S322-S322

2023

Link zum Volltext

Verfügbarkeit prüfen

425P Real world quality of life (QoL) in breast cancer (BC) patients treated with cyclin-dependent kinase 4/6 inhibitors (CDK4/6i)

Annals of oncology, 2023-10, Vol.34, p.S361-S361

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

ThemaAnimals

Zeitschrift / SerieAnnals Of Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)

Erscheinungsjahr

n.n

Kollektion

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence of BRCA and VUS mutations in patients with ovarian cancer treated at oncosalud: AUNA

P-6 Spatio-temporal distribution pattern of pancreatic cancer mortality rate in Peru between 2003-2017

P-62 Overall survival of patients with pancreatic cancer

Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

356P - Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

362P - Patterns and predictors of first-line (1L) taxane use in US patients with metastatic triple-negative breast cancer (mTNBC)

Patterns and predictors of first-line (1L) taxane use in US patients with metastatic triple-negative breast cancer (mTNBC)

The immune modulation role of low dosage of cyclosporin-A (ldCSA) in the antitumor response of CD8+ T lymphocytes (CD8+Tcells) and the implication of neuropilin-1 (Nrp1)

196P Neoadjuvant and adjuvant chemotherapy (NACT/ACT) treatment (tx) patterns in a real-world cohort of US pts with early triple-negative breast cancer (eTNBC)

233P Germline genetic testing before formal counseling: Impact in cancer management in a Spanish university hospital

271PPrevalence of BRCA and VUS mutations in patients with ovarian cancer treated at oncosalud: AUNA

1456P Impact of early palliative care in quality at the end of life in small cell lung cancer patients

A Multidisciplinary Approach to Heredofamilial Cancer Syndromes: Evaluation of the First Four Years of Experience at a Spanish University Hospital

356PUse of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

362PPatterns and predictors of first-line (1L) taxane use in US patients with metastatic triple-negative breast cancer (mTNBC)

Evaluation of breast cancer patients with genetic risk: Before and after a multidisciplinary heredofamiliar cancer unit implementation

Treatment Outcomes and Prognostic Factors in Mexican Patients with Endometrial Carcinoma: the Latin American Experience

1003P - Treatment Outcomes and Prognostic Factors in Mexican Patients with Endometrial Carcinoma: the Latin American Experience

496PA MULTIDISCIPLINARY APPROACH TO HEREDOFAMILIAL CANCER SYNDROMES: EVALUATION OF THE FIRST FOUR YEARS OF EXPERIENCE AT A SPANISH UNIVERSITY HOSPITAL

Impact of invasive lobular carcinoma in Latin American breast cancer patients’ disease-free survival: The new paradox

Association between obesity and efficacy of chemoradiotherapy in rectal cancer patients

346P Influence of single nucleotide polymorphisms in genes involved in capecitabine activation pathway on treatment toxicity in patients with colorectal cancer

350P Quality of life data on sexual relations in early breast cancer patients

Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer

425P Real world quality of life (QoL) in breast cancer (BC) patients treated with cyclin-dependent kinase 4/6 inhibitors (CDK4/6i)

Aktive Filter

Suchergebnisse filtern